Generic placeholder image

Letters in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-1786
ISSN (Online): 1875-6255

Research Article

A Simple and Efficient Path for the Synthesis Antineoplastic Agent (2R,3R,4S,5R)-5-(6-Amino-2-Chloropurin-9-yl)-4-Fluoro-2-(Hydroxymethyl) oxolan-3-ol (Clofarabine)

Author(s): Laxmi Kumari Nagarapu, Chithaluri Sudhakar* and Suresh Babu Namana

Volume 21, Issue 10, 2024

Published on: 21 February, 2024

Page: [859 - 866] Pages: 8

DOI: 10.2174/0115701786287468240209105224

Price: $65

Abstract

Clofarabine (1) is an anticancer agent used to treat acute leukemia. This work discloses the efforts to develop a convenient, environmentally benign, and high-yielding synthetic protocol leading to Clofarabine (1). The synthesis includes bromination of 2-deoxy-2-β-fluoro-1,3,5-tri-O-benzoyl-1- α-D-ribofuranose (6), followed by C-N coupling with a 2,6-dichloro purine (4) and selective amination consecutively. The proposed total synthesis comprises five steps to afford an overall yield of 65- 70% with 99.85% purity. The present process provides preparation of Clofarabine (1) using a simple purification process with lesser reaction time, better yield, and purity without using toxic and pyrophoric chemicals.

Graphical Abstract

[1]
Rosemeyer, H. Chem. Biodivers., 2004, 1(3), 361-401.
[http://dx.doi.org/10.1002/cbdv.200490033] [PMID: 17191854]
[2]
Ertl, P.; Jelfs, S.; Mühlbacher, J.; Schuffenhauer, A.; Selzer, P. J. Med. Chem., 2006, 49(15), 4568-4573.
[http://dx.doi.org/10.1021/jm060217p] [PMID: 16854061]
[3]
Legraverend, M.; Grierson, D.S. Bioorg. Med. Chem., 2006, 14(12), 3987-4006.
[http://dx.doi.org/10.1016/j.bmc.2005.12.060] [PMID: 16503144]
[4]
Schmidt, A.P.; Lara, D.R.; Souza, D.O. Pharmacol. Ther., 2007, 116(3), 401-416.
[http://dx.doi.org/10.1016/j.pharmthera.2007.07.004] [PMID: 17884172]
[5]
Nie, A.; Wang, J.; Huang, Z. J. Comb. Chem., 2006, 8(5), 646-648.
[http://dx.doi.org/10.1021/cc060053y] [PMID: 16961399]
[6]
Bobek, M.; Bloch, A.; Parthasarathy, R.; Whistler, R.L. J. Med. Chem., 1975, 18(8), 784-787.
[http://dx.doi.org/10.1021/jm00242a004] [PMID: 808609]
[7]
Ototani, N.; Whistler, R.L. J. Med. Chem., 1974, 17, 535-537.
[http://dx.doi.org/10.1021/jm00251a015] [PMID: 4830257]
[8]
Parker, W.B.; Shaddix, S.C.; Chang, C-H.; White, E.L.; Rose, L.M.; Brockman, R.W.; Shortnacy, A.T.; Montgomery, J.A.; Secrist, J.A., III; Bennett, L.L., Jr Cancer Res., 1991, 51(9), 2386-2394.
[PMID: 1707752]
[9]
Yamauchi, T.; Nowak, B.J.; Keating, M.J.; Plunkett, W. Clin. Cancer Res., 2001, 7(11), 3580-3589.
[PMID: 11705880]
[10]
Montgomery, J.A.; Shortnacy-Fowler, A.T.; Clayton, S.D.; Riordan, J.M.; Secrist, J.A., III J. Med. Chem., 1992, 35(2), 397-401.
[http://dx.doi.org/10.1021/jm00080a029] [PMID: 1732556]
[11]
Carson, D.A.; Wasson, D.B.; Esparza, L.M.; Carrera, C.J.; Kipps, T.J.; Cottam, H.B. Proc. Natl. Acad. Sci., 1992, 89(7), 2970-2974.
[http://dx.doi.org/10.1073/pnas.89.7.2970] [PMID: 1348362]
[12]
Reichelova, V.; Liliemark, J.; Albertioni, F. J. Pharm. Biomed. Anal., 1995, 13, 711.
[http://dx.doi.org/10.1016/0731-7085(95)01325-F] [PMID: 9696594]
[13]
Martin, Y.C.; Shortnacy-Fowler, A. J. Med. Chem., 1992, 35(12), 2145-2154.
[http://dx.doi.org/10.1021/jm00090a001]
[14]
Montgomery, J.A.; Fowler, A.T.; Secrist, J.A. III WO Patent 01/60383A1, 2001.
[15]
US Patent 6949640,
[16]
US Patent 6680382,
[17]
US Patent 5661136,
[18]
Sudhakar, C.H. Tetrahedron Lett., 2012, 53, 3850-3852.
[http://dx.doi.org/10.1016/j.tetlet.2012.05.032]
[19]
Sudhakar, C.; Reddy, P.R.; Kumar, C.G.; Sujitha, P.; Das, B. Eur. J. Org. Chem., 2012, 2012(6), 1253-1258.
[http://dx.doi.org/10.1002/ejoc.201101601]
[20]
Vala, M.K.; Adurthi, S.; Chithaluri, S. Synth. Commun., 2020, 51, 1-8.
[http://dx.doi.org/10.1080/00397911.2020.1858109]
[21]
Nagarapu, L.K.; Sudhakar, C.; Kondapalli, R. Tetrahedron Lett., 2023, 125, 154627.
[http://dx.doi.org/10.1016/j.tetlet.2023.154627]
[22]
Chou, T.S.; Becke, L.M.; O’Toole, J.C.; Carr, M.A.; Parker, B.E. Tetrahedron Lett., 1996, 37(1), 17-20.
[http://dx.doi.org/10.1016/0040-4039(95)02102-7]
[23]
Bauta, W.E.; Schulmeier, B.E.; Burke, B.; Puente, J.F.; Cantrell, W.R.; Lovett, D.; Goebel, J.; Anderson, B.; Ionescu, D.; Guo, R. Org. Process Res. Dev., 2004, 8(6), 889-896.
[http://dx.doi.org/10.1021/op049884n]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy